Insider Buying: Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) CEO Buys $30,362.27 in Stock

Inspira Technologies OXY B.H.N. Ltd (NASDAQ:QTEX) CEO Dagi Ben-Noon bought 18,181 shares of Inspira Technologies OXY B.H.N. stock in a transaction on Friday, October 9th. The shares were acquired at an average cost of $1.67 per share, with a total value of $30,362.27. Following the completion of the acquisition, the chief executive officer owned 3,664,314 shares of the company’s stock, valued at $6,119,404.38. The trade was a 0.50% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink.

Dagi Shahar Ben-Noon also recently made the following trade(s):

• On Monday, September 28th, Dagi Ben-Noon acquired 168,894 shares of Inspira Technologies OXY B.H.N. stock. The shares were bought at an average cost of $0.71 per share, with a total value of $119,914.74.

Inspira Technologies OXY B.H.N. Stock Performance

Inspira Technologies OXY B.H.N. stock traded up $0.07 during midday trading on Friday, reaching $1.76. The stock had a trading volume of 13,982,775 shares, compared to its average volume of 12,416,598. Inspira Technologies OXY B.H.N. Ltd has a 52-week low of $0.28 and a 52-week high of $3.85. The stock has a fifty day simple moving average of $0.94. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.00 and a quick ratio of 1.62.

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) last posted its quarterly earnings results on Thursday, September 24th. The company reported ($0.07) EPS for the quarter. The firm had revenue of $0.78 million for the quarter.

Inspira Technologies OXY B.H.N. declared that its Board of Directors has authorized a share repurchase plan on Monday, June 22nd that permits the company to repurchase 2,000,000,000,000 outstanding shares. This repurchase authorization permits the company to repurchase up to 5.6% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company’s board believes its shares are undervalued.

Wall Street Analysts Forecast Growth

QTEX has been the subject of a number of research analyst reports. Weiss Ratings raised Inspira Technologies OXY B.H.N. from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, September 25th. Wall Street Zen lowered Inspira Technologies OXY B.H.N. from a “hold” rating to a “sell” rating in a research report on Saturday, August 8th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has an average rating of “Sell”.

About Inspira Technologies OXY B.H.N.

Inspira Technologies OXY B.H.N. Ltd. is a medical technology company focused on developing advanced respiratory-support and blood-monitoring solutions for critical-care settings. The company’s technologies are intended to help address complications associated with respiratory failure and improve the management of patients requiring oxygenation support.

Its product portfolio includes the INSPIRA ART system, an extracorporeal respiratory-support platform designed to provide oxygenation while potentially reducing the need for conventional mechanical ventilation or more complex extracorporeal membrane oxygenation procedures.